Thrombosis :: UK Acute Oncology Society

Acute Oncology Guidelines

Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is an important cause of morbidity and mortality among patients with cancer.
Patients with cancer are significantly more likely to develop VTE than people without cancer and experience higher rates of VTE recurrence and bleeding complications during VTE treatment.

ESMO CLINICAL PRACTICE GUIDELINES: MANAGEMENT OF VENOUS THROMBOEMBOLISM (VTE) IN CANCER PATIENTS:

Useful links:

Cancer and Thrombosis - British Society for Haematology

ASCO Clinical Practice Guidelines- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer - Update August 2019

International Society on Thrombosis and Haemostasis here

Problem Solving in Acute Oncology (Second Edition) Complications of Cancer- case study 28 - Venous Thromboembolism written by Nick Wreglesworth, Anna Mullard and Helen Innes

What is cancer-associated thrombosis? Professor Simon Noble - You tube

Cancer Clot website here

Michael B. Streiff, Syed Ali Abutalib, Dominique Farge, Martina Murphy, Jean M. Connors, Gregory Piazza Update on Guidelines for the Management of Cancer-Associated Thrombosis First published: 04 December 2020

Lucia Caiano, Marc Carrier, Andrea Marshall, Annie M. Young, Walter Ageno, Aurélien Delluc, Tzu-Fei Wang Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysis. Journal of Thrombosis and Haemostasis First published: 23 June 2021

We are eager to develop the content of this page and would be pleased to accept contributions and suggestions, please contact us if you are able to help

Please note that you should always assume that the website group, society and authors /owners of any of these documents links or guidance make no representations or guarantees as to the accuracy, completeness or adequacy of any of the content and make no warranties express implied or otherwise and cannot be held responsible for any liability, loss or damage whatsoever caused by the use of the content. You should always act within the limits of your competence and seek senior advice or support where appropriate.

The UK Acute Oncology Society (UKAOS) is most grateful to Exact Sciences and Pfizer for their joint funding support of the Society in its inaugural year; the support from Pfizer was in the form of an unrestricted educational grant. The companies have had no influence on the set up of UKAOS.